Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-11541047-B2 United States of America 03 Jan 2023
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for… Grant US-11439620-B2 United States of America 13 Sep 2022
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP… Grant US-11253606-B2 United States of America 22 Feb 2022
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra… Grant US-11192955-B2 United States of America 07 Dec 2021
Compounds and methods for the treatment of TROP2 positive diseases Grant US-11192954-B2 United States of America 07 Dec 2021
Immunoconjugates with an intracellularly-cleavable linkage Grant US-RE48751-E1 United States of America 28 Sep 2021
Immunoconjugates with an intracellularly-cleavable linkage Grant US-11077201-B2 United States of America 03 Aug 2021
Immunoconjugates with an intracellularly-cleavable linkage Grant US-11066468-B2 United States of America 20 Jul 2021
Immunoconjugates with an intracellularly-cleavable linkage Grant US-11020489-B2 United States of America 01 Jun 2021
Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes… Grant US-10954305-B2 United States of America 23 Mar 2021
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10918721-B2 United States of America 16 Feb 2021
Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab… Grant US-10918734-B2 United States of America 16 Feb 2021
Subcutaneous administration of antibody-drug conjugates for cancer therapy Grant US-10799597-B2 United States of America 13 Oct 2020
Antibody-SN-38 immunoconjugates with a CL2A linker Grant US-10751420-B2 United States of America 25 Aug 2020
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug… Grant US-10744129-B2 United States of America 18 Aug 2020
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10682347-B2 United States of America 16 Jun 2020
Immunoconjugates with an intracellularly-cleavable linkage Grant US-10561738-B2 United States of America 18 Feb 2020
COMBINATION OF ABCG2 INHIBITORS WITH SACITUZUMAB GOVITECAN (IMMU-132) OVERCOMES… Application EP-3413914-A4 European Patent Office 16 Oct 2019
ANTI-TROP-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF Application EP-3049443-A4 European Patent Office 05 Apr 2017
ANTI-TROP-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF Application EP-3049443-A1 European Patent Office 03 Aug 2016